ClinicalTrials.Veeva

Menu

Evaluation of Inflammation of the Anterior Segment by Laser Flashmeter in Patients Having Undergone Surgery of the Posterior Segment (Vitrectomy or Preindentation) During the First Postoperative Year. (FLAVIC)

R

Rennes University Hospital

Status

Unknown

Conditions

Inflammation Eye

Treatments

Other: Laser Flare Meter

Study type

Observational

Funder types

Other

Identifiers

NCT03677700
35RC18_3043_FLAVIC

Details and patient eligibility

About

Observational study, monocentric, prospective, descriptive and comparative (eye operated vs fellow eye).

Full description

After surgery by vitrectomy or preindentation, an anti-inflammatory treatment is conventionally prescribed for a duration of 1 month. However, frequently, during the post-operative control at one month, there may be signs of ocular inflammation or symptoms of discomfort justifying the prolongation of post-operative treatment. A 2012 study evaluated post-operative flare follow-up in 22 vitrectomized patients for retinal detachment, and showed a significantly higher flare 3 months after surgery, compared to the other eye and pre-surgery value.

In this study, the investigators wish to study postoperative inflammation in patients operated for posterior segment ocular surgery (vitrectomy or preindentation) measured by laser flashmeter on a follow-up of one year.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major patient,
  • Operation of vitrectomy or preindentation in the ophthalmology department of Rennes University Hospital for one of the following reasons:
  • Retinal detachment, rhegmatogenous or not
  • Combined surgery
  • Membrane peeling
  • Macular hole
  • Optically targeted vitrectomy (Terson's syndrome, intravitreous haemorrhage)
  • Covered by a health insurance system,
  • Having received information on the protocol and not having expressed opposition to participating in the study

Exclusion criteria

  • Vitrectomy for endophthalmitis or posterior uveitis,
  • Patient with vitreoretinal proliferation (grade B and C),
  • Pregnant or nursing woman,
  • Major patient subject to legal protection (safeguard of justice, guardianship, guardianship), person deprived of liberty.

Trial contacts and locations

0

Loading...

Central trial contact

Coralie DOUDNIKOFF; Dalal ASRI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems